Prospective Evaluation of Amino Acid Profiles and Physical Function Following Tofogliflozin Initiation in Adults With Type 2 Diabetes ― The TOFLEX Study Protocol ―

Authors:

Abstract
Background: Type 2 diabetes mellitus (T2DM) is associated with cardiometabolic dysfunction and progressive impairment of skeletal muscle health. Sodium–glucose cotransporter 2 inhibitors (SGLT2I) improve cardiovascular and renal outcomes, but their effects on amino acid metabolism, skeletal muscle composition, and physical function remain unclear. β-aminoisobutyric acid (BAIBA), a muscle-related amino acid, may link metabolic regulation with muscle health.Methods and Results: The TOFLEX study is a single-center, single-arm, prospective observational study evaluating longitudinal changes after initiation of tofogliflozin in adults with T2DM. Participants aged ≥18 years who are scheduled to start tofogliflozin in routine clinical care will be followed for 48 weeks. The primary outcome is the change in circulating amino acid concentrations, with particular attention to BAIBA. Secondary outcomes include changes in urinary amino acid profiles, physical function assessed by the Short Physical Performance Battery and handgrip strength, skeletal muscle mass assessed by dual-energy X-ray absorptiometry and bioelectrical impedance analysis, intramuscular fat infiltration assessed by magnetic resonance imaging and/or spectroscopy, and cardiometabolic parameters.Conclusions: TOFLEX will provide prospective data on amino acid remodeling after SGLT2i initiation and explore its relationship with skeletal muscle composition and physical function in adults with T2DM.

This publication has 16 references indexed in Scilit: